| Stage | VSXY | % of rev | CATO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.6B | 100.00% | $166M | 100.00% | VSXY ×9.73 |
| Gross profit | $759M | 47.11% | $55M | 33.43% | VSXY +13.7pp |
| Operating income | $257M | 15.95% | $1M | 0.78% | VSXY +15.2pp |
| Pre-tax income | $248M | 15.39% | $1M | 0.78% | VSXY +14.6pp |
| Net income | $188M | 11.67% | $1M | 0.69% | VSXY +11.0pp |
| Stage | VSXY | CATO | Gap · A − B |
|---|---|---|---|
| Revenue | $1.6B100.00% | $166M100.00% | VSXY ×9.73 |
| Gross profit | 47.11%$759M | 33.43%$55M | VSXY +13.7pp |
| Operating income | 15.95%$257M | 0.78%$1M | VSXY +15.2pp |
| Pre-tax income | 15.39%$248M | 0.78%$1M | VSXY +14.6pp |
| Net income |
| 11.67%$188M |
| 0.69%$1M |
| VSXY +11.0pp |
No disclosed counterparties: CATO.
None